Antibody-drug conjugates

The Resource Antibody-drug conjugates
Label
Antibody-drug conjugates
Statement of responsibility
edited by Laurent Ducry
Contributor
Editor
Subject
Genre
Language
eng
Summary
Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. In Antibody-Drug Conjugates, expert researchers provide detailed protocols for many of the key ADC techniques necessary for working in the field. These chapters and methodologies are aimed at the key tasks necessary to identify a suitable target, properly design the mAb, the linker and the payload, as well as to conjugate them in a reproducible and scalable fashion. Written in the highly successful Methods in Molecular Biology format, these detailed chapters include the kind of practical implementation advice that guarantees quality results. Authoritative and timely, Antibody-Drug Conjugates aims to further drive ADC development and thus help toward improving cancer treatments of the future
Member of
Cataloging source
GW5XE
Dewey number
615.3/7
Illustrations
illustrations
Index
index present
Language note
English
LC call number
RS201.A56
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
  • W1
  • QW 575.5.A6
NLM item number
ME9616J v.1045 2013
Series statement
Methods in Molecular Biology,
Series volume
1045
Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by University of Missouri Libraries. Additional terms may apply to data associated with third party namespaces.
Processing Feedback ...